Fig. 4: K–M DMFS curves for patients with LARC according to the RS.
From: Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
The results are shown for all patients (n = 629, left), patients with a high RS (n = 279, middle), and patients with a low RS (n = 350, right). The results are also stratified according to adjuvant chemotherapy use (a), pT stage (b), and pN stage (c). p values were calculated using two-sided log-rank test. RS radiomic signature; HR hazard ratio; DMFS distant metastasis-free survival; LARC locally advanced rectal cancer. Source data are provided as a Source Data file.
